Neonatal Respiratory distress syndrome （NRDS）, is an acute lung disease of the newborncaused by surfactant deficiency. It is one of the most common causes of respiratory failures inpremature babies, especially in neonates younger than32weeks’ gestational age andweighing less than1200g. Ventilation was used to improve oxygenation and diseasedmortality of neonates with NRDS, but it may cause severe lung injury includingpneumothorax, ventilator-associated pneumonia and increase the incidence of chr... 

【文章來源】：華中科技大學(xué)湖北省 211工程院校 985工程院校 教育部直屬院校

【文章頁數(shù)】：47 頁

【學(xué)位級別】：碩士

【文章目錄】：
Table of Contents
Abbreviations
Abstract
Neonatal respiratory distress syndrome
History of pulmonary surfactant therapy
Synthesis of endogenous pulmonary surfactant
Composition of pulmonary surfactant
Function of Pulmonary Surfactant
Pulmonary Surfactant Preparations
Comparison of High and low dose natural surfactants
Earlier surfactant treatment policy
Benefits of exogenous pulmonary surfactant therapy in NRDS
Timing of surfactant administration
Pulmonary surfactant Usage
Surfactant therapy in other neonatal lung disease
Methods of Administration of Exogenous Pulmonary Surfactant
A Case Report
Summary
Conclusion
References
Acknowledgement


【參考文獻】：
期刊論文
[1]表面活性物質(zhì)替代治療新生兒呼吸窘迫綜合征的療效評估(英文)[J]. Sedigheh GHAEMI,Maryam MOHAMADYMASODI,Roya KELISHADI.  中國當代兒科雜志. 2009(03)



本文編號：2911131